Susan Clement Davies
Directeur/Membre du Conseil chez SCANCELL HOLDINGS PLC
Profil
Susan Elizabeth Clement Davies is currently an Independent Non-Executive Director at Science Group Plc, a Non-Executive Director at Scancell Holdings Plc, and an Independent Director at MiNA Therapeutics Ltd.
She is also a Non-Executive Director at Exploristics Ltd.
In the past, she worked as a Managing Director in Equity Capital Markets at Citigroup Global Markets Ltd.
She was also an Independent Non-Executive Director at Evgen Pharma Plc and a Managing Director at Torreya Partners LLC.
Ms. Clement Davies has a graduate degree from the London School of Economics & Political Science and an undergraduate degree from University College London.
Postes actifs de Susan Clement Davies
| Sociétés | Poste | Début |
|---|---|---|
| SCANCELL HOLDINGS PLC | Directeur/Membre du Conseil | 24/09/2020 |
| SCIENCE GROUP PLC | Directeur/Membre du Conseil | 18/05/2022 |
MiNA Therapeutics Ltd.
 MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 01/01/2022 |
| Exploristics Ltd. | Directeur/Membre du Conseil | - |
Anciens postes connus de Susan Clement Davies
| Sociétés | Poste | Fin |
|---|---|---|
| THERACRYF PLC | Directeur/Membre du Conseil | 31/12/2023 |
Torreya Partners LLC
 Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2018 |
Citigroup Global Markets Ltd.
 Citigroup Global Markets Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Ltd. (CGML) is an international broker-dealer firm headquartered in London, UK. The firm was founded in 1983 and is a subsidiary of Citigroup Global Markets Holdings Bahamas Ltd., ultimately held by Citigroup, Inc. (NYSE: C) in the US. CGML has a major presence in the international financial markets as a dealer, market-maker and underwriter in equity and fixed income securities and offers risk-based solutions to producers and investors in commodity markets. They also provide corporate finance services to a wide range of corporate, institutional and government clients. Their trading activities encompass cash, exchange traded and OTC derivative markets. | Corporate Officer/Principal | 01/01/2018 |
Formation de Susan Clement Davies
| University College London | Undergraduate Degree |
| London School of Economics & Political Science | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| THERACRYF PLC | Health Services |
| SCANCELL HOLDINGS PLC | Health Technology |
| SCIENCE GROUP PLC | Commercial Services |
| Entreprise privées | 4 |
|---|---|
Torreya Partners LLC
Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Finance |
Citigroup Global Markets Ltd.
Citigroup Global Markets Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Ltd. (CGML) is an international broker-dealer firm headquartered in London, UK. The firm was founded in 1983 and is a subsidiary of Citigroup Global Markets Holdings Bahamas Ltd., ultimately held by Citigroup, Inc. (NYSE: C) in the US. CGML has a major presence in the international financial markets as a dealer, market-maker and underwriter in equity and fixed income securities and offers risk-based solutions to producers and investors in commodity markets. They also provide corporate finance services to a wide range of corporate, institutional and government clients. Their trading activities encompass cash, exchange traded and OTC derivative markets. | Finance |
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Health Technology |
| Exploristics Ltd. |
